Recognition showcases the agency's distinction amidst its competition and the value it has added for clients

Where tactical precision, creative thinking, expert analysis, and passion provide quality outcomes.

Where tactical precision, creative thinking, expert analysis, and passion provide quality outcomes.

Where tactical precision, creative thinking, expert analysis, and passion provide quality outcomes.

For the 2nd Time, MedEvoke Appears on the Inc. 5000, Ranking No. 2180 With Three-Year Revenue Growth of 193.26 Percent

Where passion, creative thinking, expert analysis, and tactical precision results in excellence.

Where creative thinking, expert analysis, and tactical precision comes together for rewarding results.

MedEvoke, a premier provider of globally aligned, evidence-based scientific narrative development for the biopharmaceutical industry is now poised to broaden its reach with burgeoning new business, and expanded leadership roles will impact the company's scope in key growth areas: servicing global initiatives, and creating brand awareness across the therapeutic landscape.

Taking Evidence-based Global Alignment to the Next Level

The 6th Annual Pharmacovigilance & Risk Management Strategies 2016 brings together Pharmacovigilance and Drug Safety Officers, EU and National Regulatory, Clinical Risk-Benefit Groups, Regulatory Affairs Officers, Consultancies, Local Medicines Authorities, CROs and others.

Open Payment Reporting, Communicating Deadlines, Addressing Transfer of Value Among New Session Topics

Sentrx continues to add to its Business Development staff by hiring three new outstanding solution oriented individuals.

Sentrx discusses the importance of outsourcing data monitoring to a sole entity.

Sentrx, industry leader in providing outsourced drug safety solutions, comprehensive pharmacovigilance solutions and data management services, comments on new E.U. Regulations.